Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction

Eleanor M Dunican1, Brett M Elicker2, David S Gierada3

  • 1Division of Pulmonary and Critical Care Medicine, Department of Medicine and Cardiovascular Research Institute, and.

Abstract

Insights

Mucus plugs are common in severe asthma and linked to airflow obstruction. Eosinophil peroxidase may cause these plugs by oxidizing cysteine, suggesting a new treatment target.

Area of Science:

  • Pulmonary Medicine
  • Respiratory Research
  • Asthma Pathophysiology

Background:

  • The relationship between mucus plugs and airflow obstruction in chronic severe asthma remains unclear.
  • The specific role of eosinophils and their byproducts in mucus plug formation is unknown.

Purpose of the Study:

  • To establish the link between mucus plugs and airflow obstruction in severe asthma.
  • To investigate the role of eosinophils and eosinophil peroxidase (EPO) in mucus plug formation.
  • To develop and validate a method for quantifying mucus plugs using computed tomography (CT) scans.

Main Methods:

  • Developed a bronchopulmonary segment-based scoring system to quantify mucus plugs on multidetector computed tomography (MDCT) lung scans.
  • Analyzed the association between mucus plug scores, forced expiratory volume in 1 second (FEV1), and airway eosinophil counts in 146 asthma patients and 22 controls.
  • Utilized airway mucus gel models to investigate the role of eosinophil peroxidase (EPO) in oxidizing cysteine thiol groups and promoting mucus plug formation.

Main Results:

  • Mucus plugs were present in 58% of asthma patients versus 4.5% of controls, persisting in the same lung segments for years.
  • A high mucus plug score (≥ 4 segments) was significantly associated with lower FEV1 (P < 0.001) and higher sputum eosinophils and EPO levels.
  • In vitro, EPO catalyzed oxidant generation, leading to cysteine thiol group oxidation and stiffening of mucus hydrogels.

Conclusions:

  • Mucus plugs are a likely contributor to chronic airflow obstruction in severe asthma.
  • Oxidants generated by EPO may play a key role in the formation of mucus plugs.
  • Quantification of airway mucus plugging via MDCT is feasible, and targeting mucus plugs could improve airflow in severe asthma.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K